Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)
12.39
-0.24 (-1.90%)
Sep 6, 2024, 3:00 PM CST
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -408.95 | -189.45 | 1,091 | 1,059 | 806.12 | 604.96 | Upgrade
|
Depreciation & Amortization | 164.94 | 154.06 | 139.53 | 93.22 | 84.55 | 44.99 | Upgrade
|
Other Amortization | 0.19 | 0.19 | 0.19 | 0.2 | 0.23 | 0.2 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.02 | 0.04 | 0.11 | 1.03 | 0.22 | -0.13 | Upgrade
|
Asset Writedown & Restructuring Costs | 1,251 | 1,244 | 10.22 | 7.23 | 52 | -2.97 | Upgrade
|
Loss (Gain) From Sale of Investments | 82.96 | 85.58 | -24.1 | -24.57 | -10.55 | -10.69 | Upgrade
|
Provision & Write-off of Bad Debts | -3.32 | -3.32 | -0.42 | 3.22 | - | - | Upgrade
|
Other Operating Activities | 110.12 | -1.96 | -99.43 | 87.47 | 55.67 | 19.69 | Upgrade
|
Change in Accounts Receivable | -1.54 | 163.36 | -1,456 | -148.2 | -345.27 | -202.11 | Upgrade
|
Change in Inventory | 676.4 | 213.28 | -731.57 | -444.05 | -1,223 | -1,230 | Upgrade
|
Change in Accounts Payable | -27.03 | 224.66 | 1,710 | 46.82 | 11.23 | -61.64 | Upgrade
|
Change in Other Net Operating Assets | -56.7 | -21.25 | -15.1 | 13.45 | 11.51 | 5.1 | Upgrade
|
Operating Cash Flow | 1,595 | 1,619 | 595.45 | 683.63 | -565.85 | -841.38 | Upgrade
|
Operating Cash Flow Growth | 119.37% | 171.93% | -12.90% | - | - | - | Upgrade
|
Capital Expenditures | -604.61 | -419.07 | -470.08 | -440.76 | -294.36 | -115.41 | Upgrade
|
Sale of Property, Plant & Equipment | -0.61 | 0.15 | 0.11 | 0.54 | 0.12 | 0.31 | Upgrade
|
Cash Acquisitions | - | - | - | -13.87 | - | -25.58 | Upgrade
|
Investment in Securities | -1,909 | -757.47 | 36.06 | 610.72 | -887.57 | -24.94 | Upgrade
|
Other Investing Activities | -1.66 | 14.34 | 33.42 | 13.51 | 9.03 | 11.99 | Upgrade
|
Investing Cash Flow | -2,516 | -1,162 | -400.5 | 170.14 | -1,173 | -153.62 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 3,073 | 2,059 | Upgrade
|
Long-Term Debt Issued | - | 3,399 | 3,358 | 2,126 | 1,266 | - | Upgrade
|
Total Debt Issued | 4,001 | 3,399 | 3,358 | 2,126 | 4,339 | 2,059 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -2,311 | -1,011 | Upgrade
|
Long-Term Debt Repaid | - | -3,094 | -3,441 | -2,687 | - | - | Upgrade
|
Total Debt Repaid | -2,687 | -3,094 | -3,441 | -2,687 | -2,311 | -1,011 | Upgrade
|
Net Debt Issued (Repaid) | 1,314 | 305.39 | -83.41 | -560.94 | 2,028 | 1,048 | Upgrade
|
Issuance of Common Stock | - | - | 0.37 | 41.17 | 227.35 | 5.99 | Upgrade
|
Repurchase of Common Stock | -5.72 | -5.72 | -1.13 | -0.87 | -1.04 | -2.39 | Upgrade
|
Common Dividends Paid | -235.29 | -248.47 | -226.65 | -191.75 | -261.21 | -100.64 | Upgrade
|
Other Financing Activities | -6.87 | - | - | -200 | -19.57 | - | Upgrade
|
Financing Cash Flow | 1,066 | 51.2 | -310.81 | -912.39 | 1,973 | 951.38 | Upgrade
|
Foreign Exchange Rate Adjustments | 65.36 | 83.18 | -16.11 | 20.05 | -9.88 | 4.41 | Upgrade
|
Net Cash Flow | 210.74 | 591.51 | -131.97 | -38.57 | 224.78 | -39.21 | Upgrade
|
Free Cash Flow | 990.64 | 1,200 | 125.37 | 242.87 | -860.21 | -956.79 | Upgrade
|
Free Cash Flow Growth | 126.47% | 857.27% | -48.38% | - | - | - | Upgrade
|
Free Cash Flow Margin | 26.27% | 30.53% | 3.38% | 6.59% | -29.51% | -38.74% | Upgrade
|
Free Cash Flow Per Share | 0.62 | 0.76 | 0.08 | 0.15 | -0.54 | -0.61 | Upgrade
|
Cash Income Tax Paid | 179.91 | 108.86 | 91.01 | 46.06 | -5.82 | -134.78 | Upgrade
|
Levered Free Cash Flow | 1,083 | 1,068 | -540.91 | -186.72 | -1,220 | -1,079 | Upgrade
|
Unlevered Free Cash Flow | 1,134 | 1,119 | -504.75 | -129.08 | -1,184 | -1,065 | Upgrade
|
Change in Net Working Capital | -1,831 | -1,549 | 841.2 | 560.57 | 1,563 | 1,417 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.